Lucy Coccimiglio, DO
Urology · Waterford, MINPI 1134298482
Payments from drug & device makers
Across 158 payments — averaging $29.94 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Johnson & Johnson$303
- Ferring Pharmaceuticals Inc.$284
- Astellas Pharma US Inc$269
- Axonics, Inc.$258
- AbbVie$252
- Teleflex LLC$243
- plus $3K from 34 others
What the payments were for
- Food & beverage$4,33192%
- Education$1112%
- Gifts$1523%
- Entertainment$1373%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Johnson & Johnson | 7 | $303 |
| Ferring Pharmaceuticals Inc. | 9 | $284 |
| Astellas Pharma US Inc | 17 | $269 |
| Axonics, Inc. | 9 | $258 |
| AbbVie(2 entities) | 10 | $252 |
| Teleflex LLC | 2 | $243 |
| Calyxo, Inc. | 2 | $220 |
| Antares Pharma, Inc. | 12 | $209 |
| Medtronic(2 entities) | 5 | $185 |
| Olympus America Inc. | 4 | $182 |
| Photocure Inc | 3 | $181 |
| Coloplast | 9 | $174 |
| Kerecis Limited | 2 | $174 |
| Myriad Genetic Laboratories, Inc. | 8 | $144 |
| EDAP Technomed Inc | 1 | $137 |
| Sumitomo Pharma America, Inc. | 7 | $136 |
| Boston Scientific | 2 | $121 |
| Endo Pharmaceuticals Inc. | 2 | $114 |
| Amgen | 3 | $108 |
| Cook Medical LLC | 2 | $104 |
| Integra Lifesciences Corporation | 1 | $93 |
| Pfizer | 6 | $90 |
| Terumo Medical Corporation | 1 | $83 |
| Urogen Pharma, Inc. | 4 | $79 |
| 180 Medical, Inc. | 5 | $78 |
| Caldera Medical, Inc | 1 | $72 |
| Merck | 3 | $70 |
| Sun Pharmaceutical Industries Inc. | 3 | $69 |
| Tolmar Pharmaceuticals, Inc. | 3 | $51 |
| Tolmar, Inc. | 2 | $33 |
| Avyxa Pharma, LLC | 1 | $30 |
| Urovant Sciences Inc | 2 | $29 |
| Analogic Corporation | 1 | $27 |
| Therapeuticsmd, Inc. | 2 | $24 |
| Accord Healthcare, Inc. | 1 | $21 |
| Clarus Therapeutics Inc. | 2 | $20 |
| Endo USA, Inc. | 1 | $19 |
| Convatec Inc. | 1 | $17 |
| Dentsply IH Inc. | 1 | $15 |
| Ambu Inc. | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Kerecis Omega3 Marigen$607
- Barrigel$243
- Kerecis Omega3 SurgiClose$152
- ADSTILADRIN$147
- Cysview$141
- FOCAL ONE$137
- iTIND System$134
- RYBREVANT$125
- CARVYKTI$125
- CVAC Aspiration System$123
- Axonics$114
- INTERSTIM$110
- BOTOX$105
- AMS$103
How this compares
$4,731 in reported general payments places this provider in the 60th percentile of 400 urology providers in Michigan.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| MyrbetriqMirabegron | 31 | $33,211 |
| GemtesaVibegron | 31 | $30,205 |
| Tamsulosin Hcl | 216 | $5,429 |
| Potassium Citrate ErPotassium Citrate | 29 | $3,633 |
| Tolterodine Tartrate ErTolterodine Tartrate | 12 | $2,503 |
| Solifenacin Succinate | 30 | $1,660 |
| Dutasteride | 30 | $1,388 |
| Finasteride | 71 | $1,162 |
| Estradiol | 19 | $1,117 |
| Cephalexin | 60 | $951 |
| Nitrofurantoin Mono-MacroNitrofurantoin Monohyd/M-Cryst | 44 | $635 |
| Desmopressin Acetate | 11 | $593 |
| Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim | 39 | $180 |
| Terazosin Hcl | 15 | $160 |
| Hydrochlorothiazide | 13 | $75 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Astellas Pharma US IncMyrbetriq | $269 | $33,21131 claims |
| Sumitomo Pharma America, Inc.Gemtesa | $136 | $30,20531 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 60th percentile of 400 urology providers in Michigan.
Other urology in Waterford
- Jason HafronWest Bloomfield$9.9M
- Ashok ReddySterling Heights$4.9M
- Kenneth KernenTroy$3.4M
- James PeabodyDetroit$2.1M
- William RobertsAnn Arbor$973K
- Adam GadzinskiRoyal Oak$727K
- William JohnstonLivonia$675K
- Kenneth PetersRoyal Oak$590K
- Khurshid GhaniAnn Arbor$550K
- Richard BennettRoyal Oak$368K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.